<DOC>
	<DOC>NCT00544050</DOC>
	<brief_summary>The primary purpose of this study was to document the pharmacokinetic parameters of both levetiracetam and its metabolite, ucb L057, after a single dose of 20 mg/kg of levetiracetam in epileptic pediatric subjects, aged 1 month to less than 4 years.</brief_summary>
	<brief_title>Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old</brief_title>
	<detailed_description />
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>male or female between 1 month and less than 4 years diagnosis of any type of epilepsy at least 5 kg body weight using no more than two antieplieptic drugs a treatable seizure etiology epilepsy secondary to a progressive cerebral disease or any other progressively neurodegenerative disease history of status epilepticus during the 2 weeks prior to the Selection Visit history of or the presence of pseudoseizures epilepsy surgery within one year prior to the Selection Visit on a ketogenic diet taking felbamate at the Selection Visit</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Levetiracetam</keyword>
	<keyword>Keppra</keyword>
</DOC>